{{htmlmetatags>
metatag-keywords=(COVID19, Vaccins)
metatag-og:title=(Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert Rev Vaccines 2023.)
metatag-description=(Traduction du résumé de l'article : Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert review of vaccines 2023.)
metatag-og:type=article
metatag-article:published_time=2024-03-27
metatag-article:modified_time=2024-03-27
}}
{{page>:priv:keywords&nofooter&noeditbtn}}
~~NOTOC~~
{{pmid>addtt:37877219|Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older.}}
{{pmid>addhash_fr:37877219|COVID19, Vaccins}}
====== Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert Rev Vaccines 2023. ======
{{tag>COVID19 }}
{{tag>Vaccins}}
* **Proposé le :** 27/03/2024 07:07:13
* **Par :** [[:user:Bot]]
* **Avec la version du site :**
* **Revu par :**
* //Mettre votre nom d'utilisateur//
* //Mettre votre nom d'utilisateur//
{{tag>Proposé_à_relecture 2024-03 Non_attribué Non_finalisé}}
{{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}}
===== Résumé et points clés =====
{{pmid>abstract_html:37877219}}
===== Références de l'article =====
{{pmid>listgroup:37877219}}
----
{{page>:veille:pm:discussion:37877219&nofooter&nolink&noindent}}
[[:veille:pm:discussion:37877219?do=edit|Éditer la discussion]]
----
===== Références =====
~~REFNOTES~~